News

According to the company, the new location provides proximity to the large population center of Mexico City, easy access to the Ministry of Health and the ability to

Isoline leads are steroid eluting, dual coil defibrillation leads available in two fixation and two lengths models. With a fully isodiametric 7.8F lead body, Isoline leads include Easyturn:

Currently, ReceptoPharm is focused on developing novel therapies for neurological, viral, and autoimmune disorders. The contract from Celtic Biotech represents the first of such for the company. Completing

The first study, conducted by the Gruppo Italiano Malattie Ematologiche dell Adulto (GIMEMA), is an ongoing, open-label, single-stage, multicenter Phase II clinical trial, designed to evaluate the therapeutic

The patients in this Phase II clinical trial are in complete hematological remission following intense chemotherapy regimens, but retain acute lymphoblastic leukemia (ALL) cancer cells in their bone

In July 2008, Inovio and VGX Pharmaceuticals executed a definitive merger agreement, which provides for the issuance of Inovio’s securities in exchange for all of the outstanding securities

At the time of reporting, nine patients were evaluable. Overall, the objective response rate was 67%, with 33% of patients having a complete response. For the subgroup of

The findings presented are from a Phase I, dose-escalation clinical trial that evaluates the TAP compound IMGN901 used as a single agent for the treatment of multiple myeloma

Study results showed that menadione was well tolerated at all doses tested. The open-label, modified dose-escalation study assessed the bioavailability, safety and tolerability of three concentrations (0.05%, 0.1%